216 related articles for article (PubMed ID: 11473346)
1. Comparative rheological behavior of hyaluronan from bacterial and animal sources with cross-linked hyaluronan (hylan) in aqueous solution.
Milas M; Rinaudo M; Roure I; Al-Assaf S; Phillips GO; Williams PA
Biopolymers; 2001 Oct; 59(4):191-204. PubMed ID: 11473346
[TBL] [Abstract][Full Text] [Related]
2. The effect of hydroxyl radicals on the rheological performance of hylan and hyaluronan.
Al-Assaf S; Meadows J; Phillips GO; Williams PA; Parsons BJ
Int J Biol Macromol; 2000 Aug; 27(5):337-48. PubMed ID: 10998492
[TBL] [Abstract][Full Text] [Related]
3. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
Bagga H; Burkhardt D; Sambrook P; March L
J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
[TBL] [Abstract][Full Text] [Related]
4. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
Balazs EA
Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the effects of hyaluronan and aggrecan concentration and hyaluronan size on the elasticity of hyaluronan-aggrecan solutions.
Nishimura M; Kawata M; Yan W; Okamato A; Nishimura H; Ozaki Y; Hamada T; Kato Y
Biorheology; 2004; 41(5):629-39. PubMed ID: 15477669
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between molecular parameters of hyaluronic acid and viscoelasticity of synovia].
Rainer F; Katzer H; Ribitsch V
Acta Med Austriaca; 1996; 23(4):133-6. PubMed ID: 9036725
[TBL] [Abstract][Full Text] [Related]
7. An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis.
Adams ME
J Rheumatol Suppl; 1993 Aug; 39():16-8. PubMed ID: 8410879
[TBL] [Abstract][Full Text] [Related]
8. DWS microrheology of a linear polysaccharide.
Hemar Y; Pinder DN
Biomacromolecules; 2006 Mar; 7(3):674-6. PubMed ID: 16529397
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
10. The application of shear and extensional viscosity measurements to assess the potential of hylan in viscosupplementation.
al-Assaf S; Meadows J; Phillips GO; Williams PA
Biorheology; 1996; 33(4-5):319-32. PubMed ID: 8977658
[TBL] [Abstract][Full Text] [Related]
11. Effects of cross-linking molecular weights in a hyaluronic acid-poly(ethylene oxide) hydrogel network on its properties.
Noh I; Kim GW; Choi YJ; Kim MS; Park Y; Lee KB; Kim IS; Hwang SJ; Tae G
Biomed Mater; 2006 Sep; 1(3):116-23. PubMed ID: 18458391
[TBL] [Abstract][Full Text] [Related]
12. Phase behavior and rheological properties of enzymatically synthesized trehalose decanoate aqueous solutions.
Choplin L; Sadtler V; Marchal P; Sfayhi D; Ghoul M; Engasser JM
J Colloid Interface Sci; 2006 Feb; 294(1):187-93. PubMed ID: 16125719
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
Pelletier JP; Martel-Pelletier J
J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
[TBL] [Abstract][Full Text] [Related]
14. Concentration dependence of interstitial flow buffering by hyaluronan in synovial joints.
Scott D; Coleman PJ; Mason RM; Levick JR
Microvasc Res; 2000 May; 59(3):345-53. PubMed ID: 10792965
[TBL] [Abstract][Full Text] [Related]
15. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.
Adams ME; Lussier AJ; Peyron JG
Drug Saf; 2000 Aug; 23(2):115-30. PubMed ID: 10945374
[TBL] [Abstract][Full Text] [Related]
16. Role of the pH on hyaluronan behavior in aqueous solution.
Gatej I; Popa M; Rinaudo M
Biomacromolecules; 2005; 6(1):61-7. PubMed ID: 15638505
[TBL] [Abstract][Full Text] [Related]
17. A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid.
Nicholls M; Manjoo A; Shaw P; Niazi F; Rosen J
Adv Ther; 2018 Apr; 35(4):523-530. PubMed ID: 29542009
[TBL] [Abstract][Full Text] [Related]
18. Solution properties of targacanthin (water-soluble part of gum tragacanth exudate from Astragalus gossypinus).
Mohammadifar MA; Musavi SM; Kiumarsi A; Williams PA
Int J Biol Macromol; 2006 Feb; 38(1):31-9. PubMed ID: 16469374
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
20. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
